| |
Web Conference Login PageASTEPRO® 0.15% Nasal Spray
Webinar Series
This Webinar Series will showcase data on ASTEPRO® 0.15% an antihistamine nasal spray approved in August 2009 that relieves the symptoms of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR), including nasal congestion, without an added decongestant such as pseudoephedrine.
Astepro 0.15% is the first and only nasal antihistamine that’s FDA approved for:
- SAR and PAR in patients 12 years of age and older
- Once-daily dosing for seasonal allergic rhinitis in patients 12 years of age and older
This webinar series is targeted to physicians, physician assistants, nurse practitioners, pharmacists, and other healthcare professionals who treat patients with seasonal allergies and/or perennial allergic rhinitis.
Following the webinar, visit Astepro.com, to request an anatomical display for patient education purposes. Click For Physicians, e-Sampling, and follow the instructions.
|
|
 |
|
| |